Navigation Links
Geisinger study: PTSD causes early death from heart disease
Date:7/7/2008

DANVILLE, PA Vietnam veterans who experienced posttraumatic stress disorder (PTSD) were twice as likely to die from heart disease as veterans without PTSD, a new Geisinger study finds.

In a study published in the July issue of Psychosomatic Medicine, Geisinger Senior Investigator Joseph Boscarino, PhD, MPH examined the prevalence of heart disease, PTSD and other problems in more than 4,000 Vietnam veterans.

The more severe the PTSD diagnosis, the greater the likelihood of death from heart disease, the study showed.

Vietnam veterans with PTSD--like chronic smokersare at higher risk of early death from heart disease, Dr. Boscarino concluded. Boscarino equated PTSD to smoking two to three packs of cigarettes per day for more than 20 years.

PTSD causes the body to release stress hormones, which leads to the inflammation and damage to the arteries and cardiovascular system damage. Stress hormones also tend to reduce the amount of inflammation-reducing cortisol in the bodythough researchers aren't sure why.

"Increased levels of stress hormones and less cortisol from PTSD are a bad combination," Dr. Boscarino explained. "Basically, PTSD just cooks your arteries in this situation."

Dr. Boscarino previously found that people with PTSD had dramatically higher rates of chronic health problems such as psoriasis, arthritis and other inflammatory diseases.

"The science is conclusively showing that if you suffer psychological trauma, it's going to take a toll on your physical health," Dr. Boscarino said. "Getting counseling today is critical to avoiding a related problem tomorrow."

This study excluded patients with a prior history of heart disease and included a national sample of veterans, which is different from prior studies on the topic, Boscarino said.


'/>"/>

Contact: Justin Walden
jawalden@geisinger.edu
570-271-8083
Geisinger Health System
Source:Eurekalert

Page: 1

Related medicine news :

1. Geisinger saves millions in medical dollars through better supply management
2. Geisinger hosting national conference to help rural veterans cope with combat stress
3. Geisinger improves care for thousands of diabetics through use of the Electronic Health Record
4. Geisinger study: Use of digital health records improve health of the elderly
5. Geisinger and Celera to collaborate on liver disease test
6. Geisinger study: PTSD a medical warning sign for long-term health problems
7. Geisinger rheumatologists redesign osteoporosis, rheumatoid arthritis care
8. Study: 9/11 Dogs Suffered Few Health Effects
9. Study: Medicare Competitive Bidding Program Could Impede Seniors Access to Diabetes Testing Supplies
10. New NV Economic Study: Bush Medicare Cuts Undermine State and Local Economic, Jobs Base
11. Pharmaceutical study: Less hemorrhaging after stroke, but not fewer deaths

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ers from the North Pole, Textsanta.net lets parent...a , North Pole, AK (PRWEB...cies at the North Pole Santa Claus has added SMS t...lobe informed of his Christmas progress at the Nor...tment have identified a large and growing percenta...
(Date:11/26/2009)...angle Dental (RTDental), a leading dental group pr...the expansion of its services to include LUMINEERS...an. , Durham, NC (PRWE...nce that Dr. Doug Macmillan, an experienced LUMIN...vanced training seminar. RTDental’s ability...
(Date:11/26/2009)...Ennis, P.A. is offering free nationwide confidenti... control pills who have suffered a Deep Vein Throm...ack or other related cardiac issues or had their G...800-856-6405 or go to the firm’s website at ...ase evaluation form. , (P...
(Date:11/25/2009)... The Bartle Hall Convention Center...cal clinic on Dec. 9-10, when Kansas City hosts th...ninsured people. ,, "This free clinic event has...it will extend over two days instead of just one a... Sheri Wood, executive director of the Kansas City...
(Date:11/25/2009)... 25 /PRNewswire/ - Sentinelle Medical Inc., a lead...I) coils and software and Calgary Scientific Inc.,...ies, have introduced a web version of Aegis(TM) Br...s innovative interface is the first truly zero-foo...n the market. Calgary Scientific,s PureWeb(TM) pla...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
... Oct. 29, 2008 The Procter &,Gamble Company (NYSE... for,the July - September quarter to $22.0 billion...t the mid-point of the Company,s four to six perce...gs,per share increased 12 percent to $1.03 for the...
....J., Oct. 29 ConvaTec, a world-leading,developer ...r community and,hospital care, today announced tha...ent of the company,s Wound Therapeutics Business U... of four new,operating divisions -- Ostomy Care, W...
...a Sustainable Transition with SafePath,s ADA Appro...versal Voter Access, CHICO, Calif., Oct. 29 For ...isability, casting their ballot is not just,a deci...ions of voting American,s will be left to determin...
... After over 25 years of crafting sm...n selected for the 2008 Best of San Diego Award in.... based U.S. Local Business Association (USLBA). ...selected for the 2008 Best of San Diego Award in t...
... Global biochips market is forecast...each $3.4 billion by 2012. Aging population, third...viduals suffering from common chronic diseases rep... afforded by biochips have created a holistic mean...
... Lloydspharmacy campaign against th... Family star Ricky Tomlinson , ...inson has warned British men against the threat of... past and paid the price in 2007 when he was diagn...
Other Medicine News:Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 2Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 3Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 4Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 5Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 6Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 7Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 8Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 9Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 10Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 11Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 12Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 13Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 14Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 15Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 16Health News:P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth 17Health News:ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units 2Health News:SafePath(TM) Products Provides Universal Access for Ohio Voters 2Health News:Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association 2Health News:Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association 3Health News:World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc. 2Health News:World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc. 3Health News:Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease 2Health News:Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease 3
(Date:11/25/2009)... , WEST PALM BEACH, Fla., Nov. 25 /PRNewsw...ing impaired Americans, especially the 27 million ... may not be all that happy, says audiologist Cindy...HearUSA (Amex: EAR ), one of America,s largest he...ies have linked hearing loss to stress, frustratio...
(Date:11/25/2009)... , BASKING RIDGE, N.J., Nov. 25 /PRNewswire...leading the development of antithrombotic aptamers...Mazzo, PhD, CEO and President, will be presenting ...rence at the New York Palace Hotel in New York Cit...pm (EST) on Tuesday, December 1 and will include a...
(Date:11/25/2009)... , NEW YORK, Nov. 25 R...ch report is available in its catalogue: ,, M... ,, http://www.reportlinker.com/p0164330/Mam...tml ,, Rising incidence of breast cancer in in...incipal factor influencing growth in the mammograp...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Black Activist Speaks Out Against Race Preferences in Health Care Bill 52514 1Black Activist Speaks Out Against Race Preferences in Health Care Bill 52514 2AlphaRx Presents Positive Preclinical Data on Zysolin 28TM 29 Inhalable Nanoparticles at Controlled Release Society Annual Meeting 52512 1AlphaRx Presents Positive Preclinical Data on Zysolin 28TM 29 Inhalable Nanoparticles at Controlled Release Society Annual Meeting 52512 2AlphaRx Presents Positive Preclinical Data on Zysolin 28TM 29 Inhalable Nanoparticles at Controlled Release Society Annual Meeting 52512 3Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 1Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 2Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 3Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 4Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 5Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 6Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 7Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 8Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 9Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 10Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 11Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 12Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 13Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 14Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 15Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 16Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 17
...erability of TAXUS(R) Liberte(R) drug-elu...ICK, Mass. and WASHINGTON, Oct. 22 Boston,Scienti...-month data from the,pivotal TAXUS ATLAS Small Ves...XUS(R) Liberte(R) Paclitaxel-Eluting Stent System ...t significantly reduced restenosis and,maintained ...
...ty, Consistently Positive Clinical ...22 Data presented today from,Abbott,s SPIRIT III ...,positive, statistically significant clinical resu...ry Stent System at one year, including continued,c...s (MACE) and continued,non- inferior rates of targ...
Other Medicine Technology:Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions 2Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions 3Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions 4Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions 5Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 2Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 4Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 5
DErrico Perforator Drill and Enlarging Burr
Cushing Perforator Drill
Doro J-Arm Retractor System
Spoon End Periosteal
Medicine Products: